Skip to content
GLP-1 Desk
Menu
Dispatch #133

Kin Meds

Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…

Visit Kin MedsAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$149/mo (brand Wegovy)
Tirzepatide
$149/mo (brand Zepbound)
Coverage
Coverage not published
Brand-name
Yes

Line Kin Meds up against its closest alternatives. Or go one-on-one: Kin Meds vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency78/100
State access24/100
Molecule range97/100
Onboarding speed72/100
Support responsiveness78/100
Licensing & trust79/100

What the Desk likes

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Where points come off

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

The Desk's briefing — C

Best for: Readers who want compounded and brand-name GLP-1 plus a longevity stack on one platform.

Kin Meds ranks #133 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Kin Meds's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Kin Meds's site. Not medical advice; see our disclosure.

← Back to The Desk